Actively Recruiting

Phase Not Applicable
Age: 18Years - 80Years
All Genders
NCT07172295

Modulate Tremor Severity With Low-intensity Focused Ultrasound Stimulation Targeting the Deep Nucleus of Patients With Refractory Hand Tremor.

Led by National Taiwan University Hospital · Updated on 2025-09-15

12

Participants Needed

1

Research Sites

133 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The study plans to recruit 12 patients with Parkinsonian tremor, essential tremor, or dystonic tremor. After receiving NaviFUS-ctbTUS stimulation, the improvement in their tremor will be recorded.

CONDITIONS

Official Title

Modulate Tremor Severity With Low-intensity Focused Ultrasound Stimulation Targeting the Deep Nucleus of Patients With Refractory Hand Tremor.

Who Can Participate

Age: 18Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age between 18 and 80 years.
  • Diagnosis of Parkinson's disease tremor, essential tremor, or dystonic tremor with inadequate response to medication.
  • Willingness to shave hair over the treatment area for focused ultrasound.
  • Stable medication types and dosages for at least 4 weeks prior to enrollment.
  • Normal liver and kidney function (Creatinine < 1.3 mg/dL, GPT < 41 U/L).
  • Agreement to use appropriate contraception from first treatment until 6 months after last treatment if of childbearing potential or having partners of childbearing potential.
Not Eligible

You will not qualify if you...

  • Presence of intracranial implants unsuitable for MRI, such as metal clips, ventriculoperitoneal shunts, cochlear implants, DBS devices, pacemakers, or ICDs.
  • Abnormalities along the ultrasound beam path including scars, scalp conditions, wounds, atrophy, or calcification.
  • Pregnant or breastfeeding women.
  • Use of other investigational drugs.
  • Major depressive disorder with Beck Depression Inventory-II score > 30 in past year or suicidal thoughts.
  • Conditions interfering with treatment or increasing risk as judged by investigator.
  • Brain tumors, vascular malformations, or significant traumatic brain injury.
  • Significant psychiatric symptoms (Clinical Dementia Rating of 2 or higher).
  • Use of anticoagulant medications or medications that worsen tremor.
  • Tremor caused by metabolic or psychogenic reasons.
  • Coagulation disorders or abnormal coagulation test results.
  • Inability to consent or comply with study procedures.
  • Insufficient skull density for ultrasound transmission (<20%).

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

National Taiwan University Hospital Hsin-Chu Branch

Hsinchu, Hsinchu City, Taiwan, 300

Actively Recruiting

Loading map...

Research Team

K

Kai-Hsiang Kai-Hsiang, M.D.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here